His primary areas of study are Acquired immunodeficiency syndrome, Substance abuse, Psychiatry, Cohort study and Cohort. The concepts of his Acquired immunodeficiency syndrome study are interwoven with issues in Viral disease, Internal medicine and Immunology. The study incorporates disciplines such as Odds ratio, Surgery, Retrospective cohort study, Environmental health and Drug in addition to Substance abuse.
His research integrates issues of Epidemiology, Health care and Public health in his study of Psychiatry. Evan Wood combines subjects such as Sex work and Demography with his study of Cohort study. His work deals with themes such as Methadone, Gee, Heroin and Emergency medicine, which intersect with Cohort.
The scientist’s investigation covers issues in Psychiatry, Prospective cohort study, Odds ratio, Cohort and Acquired immunodeficiency syndrome. His Psychiatry research focuses on subjects like Public health, which are linked to Family medicine. His Prospective cohort study research incorporates themes from Incidence, Cohort study, Demography, Proportional hazards model and Hazard ratio.
His Cohort study research is multidisciplinary, incorporating elements of Young adult and Substance abuse. His Odds ratio study also includes fields such as
Evan Wood mostly deals with Psychiatry, Prospective cohort study, Confidence interval, Odds ratio and Demography. His work on Addiction and Stimulant as part of general Psychiatry study is frequently connected to Opioid use disorder and Longitudinal study, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Evan Wood interconnects Heroin, Harm reduction, Public health, Hazard ratio and Cohort in the investigation of issues within Prospective cohort study.
His studies link Acquired immunodeficiency syndrome with Public health. Evan Wood works mostly in the field of Cohort, limiting it down to topics relating to Cohort study and, in certain cases, Observational study. His study looks at the relationship between Demography and topics such as Mental health, which overlap with Community health and Substance abuse.
Evan Wood mainly focuses on Psychiatry, Heroin, Prospective cohort study, Demography and Harm reduction. His biological study spans a wide range of topics, including Optometry and Cohort. Heroin is the subject of his research, which falls under Drug.
His Prospective cohort study research integrates issues from Viral load, Cohort study and HIV-positive people. The various areas that he examines in his Demography study include Odds ratio, Acquired immunodeficiency syndrome and Confidence interval. His studies examine the connections between Public health and genetics, as well as such issues in Needle sharing, with regards to Incidence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
Robert S. Hogg;Benita Yip;Keith J. Chan;Evan Wood.
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
Julio S.G. Montaner;Julio S.G. Montaner;Julio S.G. Montaner;Viviane D. Lima;Viviane D. Lima;Rolando Barrios;Benita Yip.
The Lancet (2010)
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
Julio S. G. Montaner;Robert Hogg;Evan Wood;Thomas Kerr.
The Lancet (2006)
Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L
Evan Wood;Robert S. Hogg;Benita Yip;P. Richard Harrigan.
Annals of Internal Medicine (2003)
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.
Mark W Tyndall;Sue Currie;Patricia Spittal;Kathy Li.
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study
Evan Wood;Thomas Kerr;Brandon D L Marshall;Kathy Li.
Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
Brandon D. L. Marshall;M.-J. Milloy;Evan Wood;Julio S. G. Montaner.
The Lancet (2011)
The public health and social impacts of drug market enforcement: A review of the evidence
Thomas Kerr;Thomas Kerr;Will Small;Evan Wood;Evan Wood.
International Journal of Drug Policy (2005)
Safer injection facility use and syringe sharing in injection drug users
Thomas Kerr;Thomas Kerr;Mark Tyndall;Mark Tyndall;Kathy Li;Kathy Li;Julio Montaner;Julio Montaner.
The Lancet (2005)
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
Viviane D. Lima;Robert S. Hogg;P. Richard Harrigan;David Moore.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: